The report titled “Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market - Growth, Future Prospects, and Competitive Analysis, 2023 – 2030” offers strategic insights into the overall ABSSSI treatment market along with the market size and estimates for the duration 2020 to 2030. The said research study cover in-depth analysis of multiple market segments based on type of infection, pathogen, drug, and different geographies. According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic antibacterial therapy and patient hospitalization. The majority of ABSSSIs are caused by Gram-positive bacterial strains, especially Staphylococcus aureus. However, Gram-negative bacteria has high importance in specific types of infections, as well as in hospital settings.

For the purpose of this study, the global ABSSSI treatment market is segmented on the basis of drugs type into Delafloxacin, Vancomycin, Ceftaroline fosamil, Telvancin, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, TMP-SMZ, and Others. 

The global ABSSSI treatment market is also segmented on the basis of type of infections into cellulitis, abscess/boil/cyst, surgical wound, and traumatic wound. 

The global ABSSSI treatment market is segmented on the basis of type of pathogens such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, and Others. 

The geographical segmentation of ABSSSI treatment market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. 

The ABSSSI treatment market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Furiex Pharmaceuticals, Inc., GlaxoSmithKline plc, Melinta Therapeutics, Inc, Debiopharm International S.A., MerLion Pharmaceuticals Pte Ltd., Durata Therapeutics, Inc., Paratek Pharmaceuticals, Inc. and Cempra, Inc. among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market?
• Which is the largest regional market for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market worldwide?